Page last updated: 2024-08-17

medroxyprogesterone acetate and Hormone-Dependent Neoplasms

medroxyprogesterone acetate has been researched along with Hormone-Dependent Neoplasms in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	19 (28.79)	18.7374
1990's	27 (40.91)	18.2507
2000's	14 (21.21)	29.6817
2010's	5 (7.58)	24.3611
2020's	1 (1.52)	2.80

Authors

Authors	Studies
Bispo, D; Fabris, V; Gil, AM; Helguero, LA; Lamb, CA; Lanari, C	1
Akashi, D; Kato, H; Minobe, S; Okamoto, K; Shimada, C; Todo, Y	1
Amos-Landgraf, JM; Clipson, L; Dove, WF; Dunkin, E; Ederveen, AG; Groothuis, PG; Heijmans, J; Hommes, DW; Krentz, KJ; Mosselman, S; Muncan, V; Shedlovsky, A; van den Brink, GR; Wielenga, MC	1
Bottino, MC; Cerliani, JP; Fabris, VT; Giulianelli, S; Helguero, LA; Lamb, CA; Lanari, C; Molinolo, A; Soldati, R; Wargon, V	1
Giulianelli, S; Gutkind, JS; Helguero, LA; Lamb, CA; Lanari, C; Martins, R; Molinolo, AA; Soldati, R; Vanzulli, SI; Vaqué, JP; Wargon, V; Zeitlin, E	1
Besch-Williford, C; Hyder, SM; Liang, Y; Mafuvadze, B; Zhang, X	1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H	1
Kuhl, H	1
Meyer, VF	1
Abbà, C; Ambroggio, S; Campagnoli, C; Peris, C	1
Kerlikowske, K; Miglioretti, DL	1
Perlroth, FA	1
Cooper, MH	1
Benavides, F; Conti, C; Fabris, VT; Lanari, C; Merani, S	1
Aydiner, A; Karagol, H; Kucucuk, S; Saip, P; Topuz, E; Uygun, K	1
Besch-Williford, C; Brekken, RA; Hyder, SM; Liang, Y	1
Beguelin, W; Brouckaert, P; Carnevale, RP; Charreau, EH; Elizalde, PV; Frahm, I; Proietti, CJ; Rivas, MA; Rosemblit, C; Salatino, M; Sapia, S; Schillaci, R	1
Hasegawa, K; Komiyama, S; Nishio, E; Udagawa, Y; Yasue, A	1
Falautano, P; Filippeschi, S; Malfiore, C; Noseda, S; Serraglia, N; Spreafico, F	1
Di Fronzo, G; Miodini, P; Piva, L; Pizzocaro, G; Ronchi, E; Salvioni, R	1
Szarvas, Z; Zsolnai, B	1
Concolino, G; Di Silverio, F; Marocchi, A; Toscano, V	1
Aitini, E; Bajetta, E; Biganzoli, L; Bochicchio, AM; Buzzoni, R; Comella, G; D'Aprile, M; Di Leo, A; Nolè, F; Veltri, E	1
Geng, CS; Labrie, F; Lévesque, C; Li, S; Yan, X	1
Charreau, EH; Elizalde, PV; Gravano, M; Guerra, FK; Lanari, C; Lippman, ME; Lupu, R	1
Kuramoto, M; Ogawa, M; Yamashita, J	1
Charreau, EH; Dran, G; Elizalde, P; Guerra, F; Kordon, EC; Lanari, C; Molinolo, AA; Montecchia, F; Pasqualini, CD; Pazos, P	1
Charreau, EH; Dran, G; Kordon, EC; Lanari, C; Molinolo, AA; Pasqualini, CD; Pazos, P	1
Beck, T; Crombach, G; Kreienberg, R; Möbus, V; Paula, J	1
Gomi, K; Horiuchi, R; Ishida, H; Okabe, M	1
Cohen, JD; Robins, HI	1
Iacopino, F; Robustelli della Cuna, G; Sica, G	1
Lamb, C; Lanari, C; Molinolo, AA; Montecchia, MF; Pazos, P; Simian, M; Vanzulli, S	1
Denis, L	1
Abe, M; Ogawa, M; Yamashita, J	1
Charreau, E; Lamb, C; Lanari, C; Luthy, IA; Molinolo, AA; Montecchia, MF; Pazos, P; Vanzulli, S	1
Balañá, ME; Charreau, EH; Elizalde, PV; Labriola, L; Lupu, R	1
Fabris, V; Helguero, LA; Lamb, CA; Lanari, C; Lüthy, I; Merani, S; Molinolo, AA; Pagano, E; Sanjuan, N	1
Allemand, I; Bishay, K; Chevillard, S; Fouchet, P; Lebeau, J; Levalois, C; Ory, K; Therwath, A	1
Christodoulides, A; Ghilchik, MW; Koistinen, R; Reed, MJ; Seppälä, M; Teale, JD	1
Bonte, J; Vanderstappen, D	1
Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE	1
Clavel, M	1
Brockerhoff, P; Grill, HJ; Holzer, A; Kreienberg, R; Pollow, K; Rathgen, GH; Schicketanz, KH; Schwarz, V	1
Dotzlaw, H; Miller, T; Murphy, LC; Murphy, LJ; Wong, MS	1
De Lena, M; Lorusso, V; Paradiso, A; Schittulli, F; Tommasi, S	1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Reed, MJ; Shaikh, NA	1
Charreau, EH; Elizalde, PV; Kordon, E; Lanari, C; Tezón, J	1
Thurzó, L	1
Charreau, E; Dosne Pasqualini, C; Elizalde, P; Kordon, E; Lanari, C; Meiss, R	1
Børmer, O; Gundersen, S; Høst, H; Klepp, O; Kvinnsland, S; Lund, E; Lundgren, S	1
Hosono, T; Kanoh, H; Matsui, Y; Okudaira, Y	1
Bieglmayer, C; Kölbl, H; Schieder, K	1
Mullins, K; Osborne, CK; Von Hoff, DD	1
Abe, O; Enomoto, K; Fujiwara, K; Fukutomi, T; Ikeda, T; Ishii, S; Jinnaka, H; Koh, J; Nakamura, A; Tsuru, S	1
Bonte, J; Ide, P; Janssens, JP	1
Decensi, A; Pavesi, L; Prada, GA; Preti, P; Robustelli della Cuna, G; Zanon, P	1
Matsumoto, K; Noguchi, S	1
Fujimoto, J; Fujita, H; Nakata, Y; Okada, H	1
Clarke, CL; Mortel, R; Satyaswaroop, PG; Zaino, R	1
Horiuchi, R; Iino, Y; Ishida, T; Izuo, M; Kurebayashi, J; Nakamura, T; Takigawa, H	1
Okada, H	1
Bollack, C; Rougeron, G	1
Glick, JH; Haller, DG	1
Cremer, P; Kruse, B; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H	1
Blumenschein, GR; Buzdar, AU; Fraschini, G; Frye, D; Halvorson, HC; Hortobagyi, GN; Hug, V; Pinnamaneni, K; Yap, HY	1

Reviews

7 review(s) available for medroxyprogesterone acetate and Hormone-Dependent Neoplasms

Article	Year
The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocrine-related cancer, 2009, Volume: 16, Issue:2 Topics: Animals; Antineoplastic Agents, Hormonal; Carcinoma, Ductal; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone	2009
[Anti-steroid hormones for uterine cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:1 Topics: Antineoplastic Agents, Hormonal; Estrogen Antagonists; Female; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen; Uterine Neoplasms	2008
Endocrine therapy in pancreatic carcinoma. Oncology, 1998, Volume: 55 Suppl 1 Topics: Antineoplastic Agents, Hormonal; Estrogen Antagonists; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Tissue Plasminogen Activator	1998
New trends in the use of medroxyprogesterone acetate as a chemotherapeutic agent in gynecologic malignancies. European journal of gynaecological oncology, 1992, Volume: 13, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen	1992
Management of breast cancer with bone metastases. Bone, 1991, Volume: 12 Suppl 1 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Estrogens; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Palliative Care; Survival Rate	1991
[Growth of endometrial cancer and hormone]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:12 Topics: Aged; Antineoplastic Agents; Chemical Phenomena; Chemistry; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone; Thrombosis; Uterine Neoplasms	1989
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:3 Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms	1986

Trials

7 trial(s) available for medroxyprogesterone acetate and Hormone-Dependent Neoplasms

Article	Year
Steroid hormone receptors in normal and malignant human renal tissue: relationship with progestin therapy. Journal of steroid biochemistry, 1984, Volume: 21, Issue:3 Topics: Adolescent; Adult; Aged; Centrifugation, Density Gradient; Chromatography, Gel; Cytosol; Female; Humans; Kidney; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Steroid	1984
Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group. American journal of clinical oncology, 1995, Volume: 18, Issue:3 Topics: Aged; Ambulatory Care; Bone Neoplasms; Drug Synergism; Drug Therapy, Combination; Epirubicin; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Survival Analysis	1995
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996. Urology, 1998, Volume: 51, Issue:5A Suppl Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine	1998
Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study. Tumori, 1990, Apr-30, Volume: 76, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromatography, High Pressure Liquid; Drug Administration Schedule; Estrogens; Female; Fluorometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone; Randomized Controlled Trials as Topic; Tamoxifen	1990
[Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer]. Zentralblatt fur Gynakologie, 1990, Volume: 112, Issue:17 Topics: Adenocarcinoma; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1990
Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer. Breast cancer research and treatment, 1990, Volume: 17, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norway; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Tamoxifen; Up-Regulation	1990
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:3 Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms	1986

Other Studies

53 other study(ies) available for medroxyprogesterone acetate and Hormone-Dependent Neoplasms

Article	Year
Hormone-Independent Mouse Mammary Adenocarcinomas with Different Metastatic Potential Exhibit Different Metabolic Signatures. Biomolecules, 2020, 08-27, Volume: 10, Issue:9 Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Female; Glucose; Glycolysis; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Metabolome; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms, Hormone-Dependent	2020
Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:11 Topics: Antineoplastic Agents, Hormonal; Drug Administration Schedule; Dydrogesterone; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progestins; Quality of Life; Sarcoma, Endometrial Stromal; Treatment Outcome	2013
Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones. Proceedings of the National Academy of Sciences of the United States of America, 2014, Nov-18, Volume: 111, Issue:46 Topics: Adenoma; Adenomatous Polyposis Coli; Animals; Animals, Congenic; Azoxymethane; Carcinogens; Colonic Neoplasms; Dihydrotestosterone; Disease Models, Animal; Estradiol; Female; Genes, APC; Gonadal Steroid Hormones; Hormone Replacement Therapy; Humans; Male; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mutation; Neoplasms, Hormone-Dependent; Orchiectomy; Organ Specificity; Ovariectomy; Postmenopause; Random Allocation; Rats; Rats, Inbred F344; Rats, Mutant Strains; Receptors, Androgen; RNA, Messenger; Sex Distribution; Species Specificity	2014
Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. Cancer research, 2012, May-01, Volume: 72, Issue:9 Topics: Animals; Breast Neoplasms; Cell Growth Processes; Cell Nucleus; Cyclin D1; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, myc; Genes, Reporter; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Receptors, Progesterone	2012
Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors. Hormones & cancer, 2012, Volume: 3, Issue:4 Topics: Animals; Apigenin; Apoptosis; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Female; Hormone Replacement Therapy; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Postmenopause; Progesterone Congeners; Xenograft Model Antitumor Assays	2012
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:2 Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins	2013
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause; Spinal Fractures	2004
Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model. Cancer genetics and cytogenetics, 2005, Volume: 161, Issue:2 Topics: Aneuploidy; Animals; Chromosome Banding; Female; Genes, p53; In Situ Hybridization, Fluorescence; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Point Mutation; Tryptophan	2005
Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma. Medical oncology (Northwood, London, England), 2006, Volume: 23, Issue:4 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome	2006
Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics. Cancer research, 2007, Oct-15, Volume: 67, Issue:20 Topics: Angiogenesis Inhibitors; Animals; Aza Compounds; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Growth Processes; Disease Progression; Female; Humans; Medroxyprogesterone Acetate; Mice; Mifepristone; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Progesterone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2007
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways. Experimental cell research, 2008, Feb-01, Volume: 314, Issue:3 Topics: Animals; Apoptosis Regulatory Proteins; Carcinogens; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Female; Humans; JNK Mitogen-Activated Protein Kinases; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms, Hormone-Dependent; NF-kappa B; Nitriles; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Sulfones; Transcriptional Activation; Tumor Necrosis Factor-alpha	2008
Effect of medroxyprogesterone acetate on DMBA-induced rat mammary carcinoma and on immunological reactivity. European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Immunity; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasms, Hormone-Dependent; Rats	1982
Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma. Acta chirurgica Hungarica, 1984, Volume: 25, Issue:4 Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Neoplasms, Hormone-Dependent; Organoids; Uterine Neoplasms	1984
Nuclear androgen receptor as marker of responsiveness to medroxyprogesterone acetate in human renal cell carcinoma. Journal of steroid biochemistry, 1981, Volume: 15 Topics: Adenocarcinoma; Cell Nucleus; Humans; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Androgen; Receptors, Steroid	1981
Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Breast cancer research and treatment, 1995, Volume: 34, Issue:2 Topics: 17-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergism; Estradiol; Estrenes; Estrogen Antagonists; Estrone; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Uterus	1995
Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas. Cancer investigation, 1995, Volume: 13, Issue:2 Topics: Adenocarcinoma; Animals; Female; Gene Expression; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Receptors, Transforming Growth Factor beta; RNA, Messenger; RNA, Neoplasm; Transforming Growth Factor alpha; Transforming Growth Factor beta; Tumor Cells, Cultured	1995
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells. Cancer, 1995, Mar-15, Volume: 75, Issue:6 Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured	1995
Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal-growth-factor receptor content. International journal of cancer, 1994, Oct-15, Volume: 59, Issue:2 Topics: Animals; Cell Division; Epidermal Growth Factor; ErbB Receptors; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Salivary Glands	1994
Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology. Breast cancer research and treatment, 1993, Volume: 28, Issue:1 Topics: Adenocarcinoma; Animals; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Progesterone; Progestins; Receptors, Estrogen; Receptors, Progesterone	1993
[Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer]. Geburtshilfe und Frauenheilkunde, 1993, Volume: 53, Issue:1 Topics: Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent	1993
[Effect of medroxyprogesterone acetate on the anticellular activity of 5-fluorouracil against human breast and stomach cancer cells]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:5 Topics: Breast Neoplasms; Cell Division; Drug Synergism; Estrogens; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Stomach Neoplasms; Tumor Cells, Cultured	1993
Response of "benign" metastasizing leiomyoma to progestin withdrawal. Case report. European journal of gynaecological oncology, 1993, Volume: 14, Issue:1 Topics: Female; Humans; Leiomyoma; Lung Neoplasms; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone Congeners; Uterine Neoplasms	1993
Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines. International journal of cancer, 1997, Jun-11, Volume: 71, Issue:6 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Humans; Interferon-alpha; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen; Tumor Cells, Cultured	1997
[Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors]. Medicina, 1997, Volume: 57 Suppl 2 Topics: Adenocarcinoma; Animals; Child; Disease Progression; ErbB Receptors; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone	1997
Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas. The Journal of steroid biochemistry and molecular biology, 1999, Volume: 68, Issue:1-2 Topics: Adenocarcinoma; Androgens; Animals; Binding Sites; Estradiol; Female; Flutamide; Glucocorticoids; Gonanes; Hormone Antagonists; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mifepristone; Neoplasms, Hormone-Dependent; Oligonucleotides, Antisense; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured	1999
Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas. Oncogene, 1999, Nov-04, Volume: 18, Issue:46 Topics: Adenocarcinoma; Animals; Base Sequence; Carcinogens; Cell Division; DNA, Antisense; Female; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuregulin-1; Progestins; Receptor, ErbB-2; Receptor, IGF Type 1; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tumor Cells, Cultured	1999
Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Cancer research, 2001, Jan-01, Volume: 61, Issue:1 Topics: Animals; Carcinoma, Ductal, Breast; Cell Differentiation; Cell Division; Disease Models, Animal; Estradiol; Female; Immunohistochemistry; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	2001
Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines. Breast cancer research and treatment, 2001, Volume: 68, Issue:3 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; DNA Primers; Female; Gene Expression; Genes, bcl-2; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2001
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. International journal of cancer, 1992, Sep-09, Volume: 52, Issue:2 Topics: Aged; Androstenedione; Breast Neoplasms; Carrier Proteins; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen	1992
Longterm remission of multiple brain metastases with tamoxifen. Journal of neuro-oncology, 1991, Volume: 10, Issue:2 Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen	1991
[Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer]. Gynakologische Rundschau, 1991, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prospective Studies	1991
Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Cancer research, 1991, Apr-15, Volume: 51, Issue:8 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Drug Resistance; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Phenotype; Progestins; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	1991
Analysis by DNA polymerase alpha activity of human breast tumour proliferation and the effect of endocrine therapy. British journal of cancer, 1990, Volume: 62, Issue:2 Topics: Androstenedione; Antineoplastic Agents; Biopsy; Breast Neoplasms; DNA Polymerase II; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen	1990
Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice. Breast cancer research and treatment, 1990, Volume: 16, Issue:1 Topics: Adenocarcinoma; Animals; Cell Division; Cell Transformation, Neoplastic; Chromatography, High Pressure Liquid; DNA Replication; Drug Interactions; Epidermal Growth Factor; Fibroblasts; Gene Expression Regulation, Neoplastic; Insulin; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Rats; Transforming Growth Factor beta	1990
Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Breast cancer research and treatment, 1990, Volume: 17, Issue:1 Topics: Adenocarcinoma; Androgens; Animals; Drug Implants; Estrogens; Female; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Ovariectomy; Progesterone; Receptors, Estrogen; Receptors, Progesterone	1990
[Hormone dependence of malignant ovarian tumors--an in vitro model]. Geburtshilfe und Frauenheilkunde, 1989, Volume: 49, Issue:5 Topics: Adenocarcinoma; Colony-Forming Units Assay; Cystadenocarcinoma; Female; Granulosa Cell Tumor; Humans; Krukenberg Tumor; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	1989
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast cancer research and treatment, 1985, Volume: 6, Issue:3 Topics: Breast Neoplasms; Cell Line; Clone Cells; Colony-Forming Units Assay; Drug Resistance; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Neoplastic Stem Cells; Receptors, Estrogen; Tamoxifen; Tumor Stem Cell Assay	1985
[Cell cycle effects of antiestrogens and medroxyprogesterone acetate on the MCF-7 human breast cancer cell line]. Nihon Gan Chiryo Gakkai shi, 1985, Dec-20, Volume: 20, Issue:10 Topics: Breast Neoplasms; Cell Cycle; Cell Line; Cell Survival; DNA, Neoplasm; Estrogen Antagonists; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen	1985
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology. European journal of gynaecological oncology, 1986, Volume: 7, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms	1986
[Hormone therapy--recent advances]. Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:10 Topics: Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms	1987
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:10 Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms	1987
Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma. Journal of steroid biochemistry, 1987, Volume: 27, Issue:1-3 Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Differentiation; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Transplantation, Heterologous; Uterine Neoplasms	1987
[Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method]. Nihon Naibunpi Gakkai zasshi, 1987, Nov-20, Volume: 63, Issue:11 Topics: Breast Neoplasms; Cell Line; DNA, Neoplasm; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norpregnadienes; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	1987
[Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 2-1 Topics: Estrenes; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Neoplasms, Hormone-Dependent; Norethindrone; Norgestrel; Progesterone Congeners; Receptors, Progesterone; Tumor Stem Cell Assay; Uterine Neoplasms	1988
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study. American journal of clinical oncology, 1988, Volume: 11 Suppl 2 Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms	1988
Progestational agents in advanced breast cancer: an overview. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen	1986
[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors]. Onkologie, 1985, Volume: 8, Issue:2 Topics: Aminoglutethimide; Breast Neoplasms; Cholesterol; Cortisone; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Triglycerides	1985
Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer. Breast cancer research and treatment, 1985, Volume: 5, Issue:3 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone	1985